HURA
TuHURA Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.90
-0.06 ▼ -3.06%
🌙 3월 13일 7:43 PM ET (한국 3/14 08:43)
$1.95
+0.05 ▲ +2.54%
| Index | RUT | P/E | - | EPS (ttm) | -0.65 | Insider Own | 24.68% | Shs Outstand | 0.05B | Perf Week | 26.67% |
| Market Cap | 0.12B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.05B | Perf Month | 47.29% |
| Enterprise Value | 0.11B | PEG | - | EPS next Q | -0.12 | Inst Own | 10.6% | Short Float | 15.23% | Perf Quarter | 84.47% |
| Income | -0.03B | P/S | - | EPS this Y | 19.35% | Inst Trans | 2.29% | Short Ratio | 4.27 | Perf Half Y | -26.64% |
| Sales | 0.00B | P/B | 5.9 | EPS next 5Y | - | ROA | -110.91% | Short Interest | 6.97M | Perf YTD | 151.09% |
| Book/sh | 0.32 | P/C | 42.73 | EPS past 3/5Y | 88.96% 76.02% | ROE | -418.06% | 52W High | -57.21% ($4.44) | Perf Year | -4.04% |
| Cash/sh | 0.04 | P/FCF | - | Sales past 3/5Y | - | ROIC | -174.6% | 52W Low | 363.41% ($0.41) | Perf 3Y | -98.25% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 99.21% | Gross Margin | - | Volatility(W/M) | 14.69% 16.75% | Perf 5Y | -99.95% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.22 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 0.4 | EPS Q/Q | 95.33% | Profit Margin | - | RSI (14) | 68.18 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.4 | Sales Q/Q | - | SMA20 | 24.28% ($1.53) | Beta | -0.34 | Target Price | $9 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2026/02/25 | SMA50 | 80.96% ($1.05) | Rel Volume | 0.58 | Prev Close | $1.96 |
| Employees | 19 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 2.68% - | SMA200 | -5.98% ($2.02) | Avg Volume(3M) | 1.63M | Price | $1.9 |
| IPO | 2013/2/22 | Option/Short | No/Yes | Trades | 3861 | Volume | 940,294 | Change | -3.06% |
뉴스 로딩 중...